Nisa Investment Advisors
IPSC icon

Nisa Investment Advisors’s Century Therapeutics IPSC Stock Holding History

Nisa Investment Advisors’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16K Hold
883
– – ﹤0.01% 2740
2026
Q1 		$2K Hold
883
– – ﹤0.01% 2616
2025
Q4 		$878 Hold
883
– – ﹤0.01% 2731
2025
Q3 		$440 Sell
883
-379
-30% -$204 ﹤0.01% 2870
2025
Q2 		$705 Buy
1,262
+962
+321% +$516 ﹤0.01% 2808
2025
Q1 		$143 Sell
300
-677
-69% -$509 ﹤0.01% 2948
2024
Q4 		$987 Buy
977
+841
+618% +$1.15K ﹤0.01% 2688
2024
Q3 		$233 Sell
136
-575
-81% -$1.13K ﹤0.01% 2832
2024
Q2 		$1.81K Buy
711
+600
+541% +$1.9K ﹤0.01% 2386
2024
Q1 		$464 Hold
111
– – ﹤0.01% 2509
2023
Q4 		$369 Buy
+111
New +$202 ﹤0.01% 2464
2023
Q3 		– Sell
-5,941
Closed -$18.8K – 2802
2023
Q2 		$18.8K Buy
5,941
+5,902
+15,133% +$19K ﹤0.01% 2125
2023
Q1 		$0 Buy
+39
New +$171 ﹤0.01% 2601
2022
Q4 		– Sell
-12,000
Closed -$126K – 2638
2022
Q3 		$126K Buy
+12,000
New +$126K ﹤0.01% 1408

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Nisa Investment Advisors's IPSC Position: Q2 2026 in Review

Nisa Investment Advisors held its Century Therapeutics (IPSC) position steady in Q2 2026 at 883 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2740.

Nisa Investment Advisors first reported a position in IPSC in Q3 2022 and has held it in 14 quarters since. The position peaked at $126K in Q3 2022. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Nisa Investment Advisors held 883 shares of Century Therapeutics worth $2.16K as of Q2 2026.
  • Nisa Investment Advisors left its Century Therapeutics share count unchanged in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2740 holding.
  • Nisa Investment Advisors first reported a position in Century Therapeutics in Q3 2022 and has held it in 14 quarters since.
  • Nisa Investment Advisors's Century Therapeutics position peaked at $126K in Q3 2022.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.